Your Location：
Home >
Browse articles >
Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC
Updated：2025-04-18
Previous|Next

    • Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress via Nrf2/ROS/PERK/CHOP Signaling Pathway to Attenuate Cisplatin Resistance in NSCLC

    • “The latest research has found that Bu Zhong Yi Qi Tang regulates endoplasmic reticulum stress and improves cisplatin resistance in non-small cell lung cancer through the Nrf2/ROS/PERK/CHOP signaling pathway.”
    • LI He , LIU Yuetong , HUANG Jingyi , MU Qirui , LIU Chunying , GAO Yuan
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 31, Issue 10, Pages: 79-89(2025)

    • DOI： 10.13422/j.cnki.syfjx.20242025     

      CLC：

    • Accepted：06 March 2025 ，

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 4 ) Tabs( 5 )

  • Editor's note

  • References

  • Publication Info

  • Metrics

481

Views

521

Downloads

2

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Buzhong Yiqitang Regulates Endoplasmic Reticulum Stress to Attenuate Cisplatin Resistance in Non-small Cell Lung Cancer via Nrf2/ROS Pathway
Mechanism of Shenmai Injection to Improve Cisplatin Resistance in NSCLC Based on Endoplasmic Reticulum Stress Through PERK/ATF4/CHOP Signaling Pathway
Apoptosis Regulation by Buzhong Yiqitang via PERK/eIF2α/ATF4/CHOP Pathway to Enhance Pulmonary Surfactant-associated Protein C Expression and Ameliorate Lung Injury in CIH Mice
Effect of Shengui Jiangtang Formula on Glucose and Lipid Metabolism in Type 2 Diabetic db/db Mice via PI3K/Akt/FoxO1 Signaling Pathway and Underlying Mechanisms
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway

Related Author

YU Dan
MU Qirui
LI He
LIU Yuetong
HUANG Jingyi
GAO Yuan
GUO Shengnan
CAO Hao

Related Institution

College of Integrated Chinese and Western Medicine， Liaoning University of Traditional Chinese Medicine
Liaoning University of Traditional Chinese Medicine
Liaoning Jinqiu Hospital
Hebei University of Chinese Medicine
Hebei Technology Innovation Center of TCM Combined with Hydrogen Medicine